Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Nordic Nanovector ASA

Headquarters: Oslo, Norway
Website: N/A
Year Founded: 2009
Status: Merged

BioCentury | Mar 13, 2024
Management Tracks

IDRx names Clackson, Dahms to C-suite and Auspitz chair

Plus: new COO for radiopharma 
BioCentury | Dec 1, 2023
Product Development

Radiopharmaceuticals’ multi-dimensional next wave

Target, ligand and radioisotope choices fuel the growing field
BioCentury | Aug 29, 2023
Management Tracks

Crossover-backed Arbor names Tamboli CFO

Plus: Atkinson named chief technical operations officer at Vertex, and updates from Confo, Flagship, Citryll and more
BioCentury | Jun 29, 2023
Management Tracks

Dallas replaces Cunningham as CEO of Rivus

Plus: Stephen Uden named CEO at Rallybio, and updates from Alloy, TScan and more
BioCentury | May 17, 2023
Management Tracks

FDA veteran Dunn to join Prothena’s board

Plus: Lucera named CFO at Editas, and updates from Erasca, Sangamo, AlloVir and more
BioCentury | Apr 19, 2023
Management Tracks

Astria promotes Matthews to CBO

Plus Engimmune hires Nieba as CEO and an update from Cardurion
BioCentury | Feb 3, 2023
Management Tracks

Graham named CEO of Roche Pharmaceuticals

Plus: Goswami becomes CFO at Illumina, and updates from SOBI, BDGene, Nordic and more
BioCentury | Dec 2, 2022
Regulation

Dec. 1 Quick Takes: FDA approves Rigel, Forma therapy for AML

Plus: Pfizer, Roivant form new unit around ulcerative colitis target, China’s Trinomab raises over $100M and updates from Nordic-APIM, Nectin, NIST and more
BioCentury | Nov 11, 2022
Regulation

Nov. 10 Quick Takes: BrainStorm falls on refusal-to-file letter from FDA

Plus: AZ dropping U.S. plans for Vaxzevria and updates from Neuraxpharm, Minoryx and more
BioCentury | Aug 26, 2022
Management Tracks

Leading China biotechs Everest, CStone announce CEO departures

Plus updates from BD, Sema4, 
Items per page:
1 - 10 of 48